These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

679 related items for PubMed ID: 14584211

  • 1. [Therapy of erectile dysfunction. Hard facts support sildenafil].
    MMW Fortschr Med; 2003 Sep 04; 145(35-36):50-1. PubMed ID: 14584211
    [No Abstract] [Full Text] [Related]

  • 2. Re: Long-term efficacy of sildenafil and tachyphylaxis effect.
    Carson CC.
    J Urol; 2002 Jul 04; 168(1):205. PubMed ID: 12073960
    [No Abstract] [Full Text] [Related]

  • 3. Vasoactive pharmacotherapy to cure erectile dysfunction: fact or fiction?
    Burnett AL.
    Urology; 2005 Feb 04; 65(2):224-30. PubMed ID: 15708027
    [No Abstract] [Full Text] [Related]

  • 4. Oral drug treatment of erectile dysfunction.
    Int J Impot Res; 2003 Dec 04; 15 Suppl 7():S27-9. PubMed ID: 14695970
    [No Abstract] [Full Text] [Related]

  • 5. [In sex dysfunctions--not just a "male issue". Don't forget women].
    MMW Fortschr Med; 2003 Sep 04; 145(35-36):51. PubMed ID: 14584212
    [No Abstract] [Full Text] [Related]

  • 6. Tachyphylaxis and phosphodiesterase type 5 inhibitors.
    Steers WD.
    J Urol; 2002 Jul 04; 168(1):207. PubMed ID: 12050542
    [No Abstract] [Full Text] [Related]

  • 7. [Comparison of efficacy and safety of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction].
    Chen Q, Wang N, Yao F, Lu X.
    Zhonghua Nan Ke Xue; 2004 Apr 04; 10(4):302-4. PubMed ID: 15148932
    [Abstract] [Full Text] [Related]

  • 8. [7 years PDE-5 inhibitor for therapy of erection disorders].
    Krankenpfl J; 2005 Apr 04; 43(7-10):267. PubMed ID: 16518894
    [No Abstract] [Full Text] [Related]

  • 9. [Levitra (vardenafil)--a new PDE 5 inhibitor for the treatment of erectile dysfunction].
    Katsarov M.
    Akush Ginekol (Sofiia); 2004 Apr 04; 43 Suppl 1():31-2. PubMed ID: 15323315
    [No Abstract] [Full Text] [Related]

  • 10. [New PDE-5 inhibitor for treatment of impotence. 9 out of 10 have erections again].
    MMW Fortschr Med; 2003 Jun 26; 145(26):59. PubMed ID: 12916343
    [No Abstract] [Full Text] [Related]

  • 11. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus.
    Vickers MA, Satyanarayana R.
    Int J Impot Res; 2002 Dec 26; 14(6):466-71. PubMed ID: 12494279
    [Abstract] [Full Text] [Related]

  • 12. [Pharmacotherapy of erectile dysfunction].
    Shcheplev PA, Nesterov SN, Kukharkin SA, Abdullaev IA, Sidorov DV.
    Ter Arkh; 1999 Dec 26; 71(10):76-8. PubMed ID: 10612182
    [No Abstract] [Full Text] [Related]

  • 13. Phosphodiesterase 5 inhibitors for erectile dysfunction.
    Setter SM, Iltz JL, Fincham JE, Campbell RK, Baker DE.
    Ann Pharmacother; 2005 Dec 26; 39(7-8):1286-95. PubMed ID: 15941818
    [Abstract] [Full Text] [Related]

  • 14. [Patients ask for sildenafil--how to treat?].
    Lukkarinen O, Tapanainen J.
    Duodecim; 1999 Dec 26; 115(7):807-10. PubMed ID: 11859515
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy.
    Raina R, Lakin MM, Agarwal A, Mascha E, Montague DK, Klein E, Zippe CD.
    Urology; 2004 May 26; 63(5):960-6. PubMed ID: 15134989
    [Abstract] [Full Text] [Related]

  • 16. PDE-5 inhibitors: current status and future trends.
    Masson P, Lambert SM, Brown M, Shabsigh R.
    Urol Clin North Am; 2005 Nov 26; 32(4):511-25, viii. PubMed ID: 16291042
    [Abstract] [Full Text] [Related]

  • 17. Sildenafil in the treatment of erectile dysfunction.
    Budenholzer B.
    N Engl J Med; 1998 Sep 03; 339(10):701-2. PubMed ID: 9729142
    [No Abstract] [Full Text] [Related]

  • 18. Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED.
    Boyle CD, Xu R, Asberom T, Chackalamannil S, Clader JW, Greenlee WJ, Guzik H, Hu Y, Hu Z, Lankin CM, Pissarnitski DA, Stamford AW, Wang Y, Skell J, Kurowski S, Vemulapalli S, Palamanda J, Chintala M, Wu P, Myers J, Wang P.
    Bioorg Med Chem Lett; 2005 May 02; 15(9):2365-9. PubMed ID: 15837326
    [Abstract] [Full Text] [Related]

  • 19. Erectile dysfunction in patients with coronary artery disease.
    Kloner R, Padma-Nathan H.
    Int J Impot Res; 2005 May 02; 17(3):209-15. PubMed ID: 15729374
    [Abstract] [Full Text] [Related]

  • 20. Erectile dysfunction, sildenafil and cardiovascular risk.
    Langton PE.
    Med J Aust; 2000 Oct 16; 173(8):446. PubMed ID: 11090041
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.